SETDB-1: A potential epigenetic regulator in breast cancer metastasis

Citations of this article
Mendeley users who have this article in their library.


The full epigenetic repertoire governing breast cancer metastasis is not completely understood. Here, we discuss the histone methyltransferase SET Domain Bifurcated Histone Lysine Methyltransferase 1 (SETDB1) and its role in breast cancer metastasis. SETDB1 serves as an exemplar of the difficulties faced when developing therapies that not only specifically target cancer cells but also the more elusive and aggressive stem cells that contribute to metastasis via epithelialto-mesenchymal transition and confer resistance to therapies.




Batham, J., Lim, P. S., & Rao, S. (2019, August 1). SETDB-1: A potential epigenetic regulator in breast cancer metastasis. Cancers. MDPI AG.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free